Details of the Drug Formulations

General Information of Drug (ID: DM5SXUV)

• Drug Name: Repaglinide Drug Info
• Synonyms: Actulin; GlucoNorm; NovoNorm; Prandin; Repaglinida; Repaglinidum; Glaxo Wellcome brand of replaginide; Novo Nordisk brand of repaglinide; Repaglinide [USAN]; Novo Nordisk brand 2 of repaglinide; AG-EE 388; AG-EE 388 ZW; AG-EE 623 ZW; AGEE-623ZW; GlucoNorm (TN); NN-623; NovoNorm (TN); Prandin (TN); Repa-glinide; Repaglinida [INN-Spanish]; Repaglinidum [INN-Latin]; SMP-508; AG-EE-388; AG-EE-623 ZW; Prandin, GlucoNorm, NovoNorm, Repaglinide; Repaglinide (JAN/USP/INN); Repaglinide, (+-)-isomer; (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid; (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid; (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid; 111GE012; 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid; 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid; 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid; 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid; 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid

Indication

Disease Entry	ICD 11	Status	REF
Diabetic complication	5A2Y	Approved	[1]

• Therapeutic Class: Hypoglycemic Agents
• Cross-matching ID:
  PubChem CID: 65981
  ChEBI ID: CHEBI:8805
  CAS Number: 135062-02-1
  TTD ID: D0N5YA
  VARIDT ID: DR00446
  INTEDE ID: DR1404
  ACDINA ID: D00587

Full List of Drug Formulations Containing This Drug

Repaglinide 2 mg tablet

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F18920	Sodium lauryl sulfate; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
Avera McKennan Hospital; Mylan Pharamceuticals	F18921	Sodium lauryl sulfate; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Paddock Laboratories,	F18916	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Citron Pharma	F18918	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
Aurobindo Pharma	F18919	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
American Health Packaging	F18917	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Poloxamer 181; Povidone, unspecified; Starch, corn
Gemini Pharmaceuticals	F18922	Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
AvKARE; Sun Pharmaceutical Industries	F18923	Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
Gemini Pharmaceuticals	F18924	Magnesium stearate; Meglumine; Ferric oxide red; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
Sandoz	F18915	Magnesium stearate; Meglumine; Ferric oxide yellow; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Breckenridge Pharmaceutical; Golden State Medical Supply	F18925	Magnesium stearate; Ferric oxide red; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium

Repaglinide 1 mg tablet

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F18909	Sodium lauryl sulfate; Fd&c blue no. 1; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
Mylan Pharamceuticals	F18910	Sodium lauryl sulfate; Fd&c blue no. 1; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Paddock Laboratories,	F18905	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Citron Pharma	F18907	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
Aurobindo Pharma	F18908	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
American Health Packaging	F18906	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Poloxamer 181; Povidone, unspecified; Starch, corn
AvKARE; Sun Pharmaceutical Industries	F18911	Magnesium stearate; Meglumine; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
Gemini Pharmaceuticals	F18913	Magnesium stearate; Meglumine; Ferric oxide yellow; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Poloxamer 181; Povidones; Starch, corn
Sandoz	F18904	Magnesium stearate; Meglumine; Ferric oxide yellow; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Cardinal Health	F18912	Magnesium stearate; Meglumine; Ferric oxide red; 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)); Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Poloxamer 124; Povidones; Starch, corn
Breckenridge Pharmaceutical; Golden State Medical Supply	F18914	Magnesium stearate; Ferric oxide yellow; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium

Repaglinide 0.5 mg tablet

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F18900	Sodium lauryl sulfate; Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Polacrilin potassium; Povidone, unspecified; Starch, corn
Mylan Pharamceuticals	F18901	Sodium lauryl sulfate; Magnesium stearate; Meglumine; Butylated hydroxyanisole; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Paddock Laboratories,	F18897	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 407; Silicon dioxide; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Citron Pharma	F18898	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 188; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Starch, corn
Aurobindo Pharma	F18899	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerin; Poloxamer 188; Povidone; Microcrystalline cellulose; Polacrilin potassium; Starch, corn
Lake Eire Medical & Surgical Supply DBA Quality Care Products	F18896	Magnesium stearate; Meglumine; Anhydrous dibasic calcium phosphate; Glycerol formal; Povidone; Cellulose, microcrystalline; Polacrilin potassium; Poloxamer 124; Starch, corn
Sandoz	F18903	Magnesium stearate; Meglumine; Glycerin; Talc; Poloxamer 188; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium; Povidones; Starch, corn
Breckenridge Pharmaceutical; Golden State Medical Supply	F18902	Magnesium stearate; Poloxamer 407; Povidone k30; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Polacrilin potassium

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6841).